NL-OMON51031招募中不适用
Studying coagulation in COVID-19 using blood-vessel-on-chip technology. - COV-AGULATE
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 36
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •1) Age >18 yr or older
- •2) Suspected SARS-CoV-2 infection
- •3) Need for oxygen supplementation
- •4) CRP-level * 50 mg/L
- •5) D-dimer level *1.0 mg/L
- •6) Ability to provide written informed consent
排除标准
- •1) History of venous thromboembolism
- •2) Use of anticoagulant therapy at inclusion
- •3) Known hereditary or acquired thrombophilia
研究者
相似试验
招募中
不适用
Studying coagulation specific for COVID-19 using Blood-vessel-on-chip technology.COVID-19NL-OMON27363ZonMw24
尚未招募
不适用
A study of blood group in COVID-19 patients admitted at tertiary care hospital, AhmedabadCTRI/2021/01/030344Arpit Prajapati
进行中（未招募）
1 期
A Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 PandemicCoagulopathy of COVID-19 appears to afflict approximately 20% of patients with severe COVID-19 and is associated with need for critical care and death. COVID-19 coagulopathy is characterized by elevated D-dimer, an indicator of fibrin formation and clot lysis, and a mildly prolonged prothrombin time (PT), suggestive of coagulation consumptionEUCTR2020-002190-10-IEniversity College Dublin24
已完成
不适用
Blood Coagulation Abnormalities in COVID-19 (Corona Virus Disease-19) PatientsCovid19NCT04982263Sohag University125
招募中
不适用
se of Convalescent Plasma in the treatment of COVID-19IRCT20200414047072N1Hilton Pharma Pvt. Ltd.357